Login
Subscribe
Cross-Resistance: One Cancer Therapy Can Undermine the Next
Cross-Resistance: One Cancer Therapy Can Undermine the Next
Targeted cancer therapy may jeopardize the effectiveness of subsequent immunotherapy by reducing dendritic cell numbers and activation, according to study of mice and patient samples.
Targeted cancer therapy may jeopardize the effectiveness of subsequent immunotherapy by reducing dendritic cell numbers and activation, according to study of mice and patient samples.
melanoma, cell & molecular biology
Starvation Response Triggers Melanoma Invasion
Catherine Offord | Apr 1, 2017 | 2 min read
Through similar mechanisms, amino acid depletion in culture and cytokine activity in the tumor microenvironment prompt cancer cells to metastasize.
Antioxidants May Aid Cancer
Kerry Grens | Oct 16, 2015 | 2 min read
Mice given a dietary supplement had faster-progressing melanoma, a study shows.
The Dark Side of Melanin
Anna Azvolinsky | Feb 19, 2015 | 3 min read
Researchers uncover a previously unknown way UV light can act on melanin, spurring cancer-causing mutations hours after sun exposure.
Gingers More Prone to Skin Cancer
Jef Akst | Nov 1, 2012 | 2 min read
Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.
Cancer Exosomes Promote Metastasis
Jef Akst | May 29, 2012 | 1 min read
Vesicles released by melanoma cells stimulate pro-metastasis behaviors in bone marrow cells.
The “Me Decade” of Cancer
Sarah Greene | Apr 1, 2011 | 3 min read
Drugs that target specific tumors are harbingers of a new era of genetically informed medicine.